Related references
Note: Only part of the references are listed.Prognostic Value of Metabolic Tumor Burden from F-18-FDG PET in Surgical Patients with Non-small-cell Lung Cancer
Hao Zhang et al.
ACADEMIC RADIOLOGY (2013)
Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Improve Outcome Prediction in Early-Stage Non-Small Cell Lung Cancer After Surgical Resection
Seung Hyup Hyun et al.
ANNALS OF SURGERY (2013)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer
Hao Zhang et al.
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2013)
Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
Karen-Lise Garm Spindler et al.
CLINICAL CANCER RESEARCH (2012)
Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
Elizabeth A. Punnoose et al.
CLINICAL CANCER RESEARCH (2012)
Measurement of Circulating Cell-Free DNA in Relation to 18F-Fluorocholine PET/CT Imaging in Chemotherapy-Treated Advanced Prostate Cancer
Sandi Kwee et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2012)
Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation
Tony S. K. Mok et al.
DRUGS (2012)
Prognostic value of metabolic tumor burden on F-18-FDG PET in nonsurgical patients with non-small cell lung cancer
Shengri Liao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy
Yoshiaki Zaizen et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer
Keunyoung Kim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non-Small Cell Lung Cancer
Helen H. W. Chen et al.
RADIOLOGY (2012)
Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
Leticia De Mattos-Arruda et al.
FUTURE ONCOLOGY (2011)
Improved Classification of Epithelial Ovarian Cancer Results of 3 Danish Cohorts
Karina Dahl Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
The Surgical Management of Stage I and Stage II Lung Cancer
Lyall A. Gorenstein et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2011)
The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer
Joerg Ellinger et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Metabolic tumor burden predicts for disease progression and death in lung cancer
Percy Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
First line chemotherapy in advanced or metastatic NSCLC
M. Rinaldi et al.
ANNALS OF ONCOLOGY (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
EUROPEAN JOURNAL OF CANCER (2005)
Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET
WH Hsu et al.
CANCER INVESTIGATION (2003)
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions - A meta-analysis
MK Gould et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
